Directory › Siegfried
Siegfried — Hameln
Hameln, Germany · CDMO
Site facts
- Company
- Siegfried
- Name(s) in FDA data
- Siegfried Hameln GmbH
- FEI number(s)
- 3002807877 (present in FDA Data Dashboard records for this name and city)
- Location (as in FDA data)
- Hameln, Germany
- Records matched
- 7 FDA inspections · 1 inspection with posted 483 citations · 1 warning letter
- Most recent FDA inspection in dataset
- 29 Aug 2024 — VAI
Capabilities (from the company's website)
- Sterile fill-finish
…n is one of Siegfried’s six Drug Products sites globally. It is a leading manufacturer of parenteral solutions, producing a wide range of aseptic and terminally sterilized products in PFS, c…
Taken from the part of the company's network/locations page that describes this site. Source: https://www.siegfried.ch/company/locations/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.
Regulatory timeline
Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.
-
29 Aug 2024FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002807877, inspection ID 1338372)
-
01 Sep 2022FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002807877, inspection ID 1203347)
-
24 Apr 2018FDA inspection FDA inspection classified NAI
No Action Indicated (NAI). Product type(s): Devices, Drugs. Project area(s): Compliance: Devices; Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002807877, inspection ID 1050123)
-
01 Jul 2016FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002807877, inspection ID 987428)
-
25 Jul 2014Form 483 observations 3 posted Form 483 citation(s)
Citation summaries (3)
- 21 CFR 211.180(e): Records reviewed annually
- 21 CFR 211.25(a): GMP Training Frequency
- 21 CFR 211.25(a): Training--operations, GMPs, written procedures
Source: FDA Data Dashboard – Citations (FEI 3002807877, inspection ID 887446)
-
25 Jul 2014FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002807877, inspection ID 887446)
-
21 Dec 2012Warning letter FDA warning letter (Drugs)
Compliance action recorded by FDA for FEI 3002807877; case/injunction ID 363318.
Source: FDA Data Dashboard – Compliance Actions (FEI 3002807877, case 363318)
-
14 Jun 2012FDA inspection FDA inspection classified OAI
Official Action Indicated (OAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002807877, inspection ID 786813)
-
09 Nov 2009FDA inspection FDA inspection classified VAI
Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.
Source: FDA Data Dashboard – Inspections (FEI 3002807877, inspection ID 637807)
This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.